Neurobehavioral effects of prevalent toxicants in children
常见毒物对儿童神经行为的影响
基本信息
- 批准号:6657529
- 负责人:
- 金额:$ 17.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-30 至 2003-08-31
- 项目状态:已结题
- 来源:
- 关键词:clinical chemistry clinical research embryo /fetus toxicology environmental exposure environmental toxicology hearing tests human subject infant human (0-1 year) lead poisoning longitudinal human study neuropsychological tests neurotoxins pesticide biological effect prenatal stress preschool child (1-5)
项目摘要
DESCRIPTION (provided by applicant)
Epidemiologic and experimental data have established the adverse
neurobehavioral effects of exposure in utero and during early childhood to
numerous environmental toxicants, including lead, alcohol, mercury, PCB s, and
environmental tobacco smoke (ETS). Still, the ideal biomarker for measuring
in utero exposure to specific toxicants has not been established and the
adverse effects of many potential neurotoxicants have not been rigorously
tested. Fetal exposure is typically measured with self-reported surveys,
maternal blood and urine, or cord blood. In contrast, meconium is a non-invasive
method to simultaneously test for chronic exposures to numerous
toxicants, but it is as yet unclear whether conventional biomarkers or
meconium are more predictive of the adverse effects linked with specific
toxicants. For lead exposure, emerging data indicate that our efforts should
emphasize primary prevention, but the safety and efficacy of lead hazard
controls are uncertain, especially for children with low blood lead
concentrations. The investigators propose to conduct a longitudinal cohort
study of 400 children, followed from less than 16 weeks gestation to 36 months
of age, to examine the dose-response of low-level exposures (pre- and
postnatal) to prevalent neurotoxicants with neurobehavioral outcomes and
development disorders, such as conduct disorder, cognitive deficits, hearing
loss and behaviors consistent with ADHD. The investigators will also conduct
a nested, randomized controlled trial to test the efficacy of lead hazard
controls or the development of adverse neurobehavioral effects. In Project 1
of University of California's Center Grant, the investigators will test the
following hypotheses: 1) In utero exposures as measured by survey (alcohol and
ETS), maternal and cord blood (lead, mercury, pesticides and ETS), and urine
(pesticides) are less predictive of in utero effects of prevalent toxicants,
such as cognition, behavioral problems, growth and hearing, compared with the
same toxicants in meconium. 2) Postnatal exposures to pesticides, ETS and
lead (at blood levels below 10 ug/dl) are associated with adverse
neurobehavioral effects, growth delay and hearing loss in early childhood. 3)
Children in the Lead Reduction Group will have blood lead levels that are 2.7
ug/dl (30%) or lower, significantly higher cognitive scores, less hearing
loss, greater growth velocity, and fewer behavioral problems than the Control
Group at 36 months of age.
If funded, this project, combined with the specific aim of Project 2, to
validate meconium as a marker of in utero exposure, will serve as a model to
evaluate the adverse effects of exposures to multiple prevalent toxicants,
validate meconium as a measure of in utero exposures to numerous toxicants,
provide exposure and risk assessment data for residential pesticides, test an
intervention for the primary prevention of subclinical lead toxicity, and test
the efficacy of a lead hazard control on children?s blood lead concentration
and neurobehavioral functioning.
描述(由申请人提供)
流行病学和实验数据已经确定了不利的
子宫内和幼儿期暴露对神经行为的影响
许多环境毒物,包括铅、酒精、汞、多氯联苯,
环境烟草烟雾(ETS)。尽管如此,理想的生物标志物,
子宫内暴露于特定毒物尚未确定,
许多潜在的神经毒物的副作用还没有被严格地
测试.胎儿暴露通常通过自我报告的调查来测量,
母体血液和尿液或脐带血。相反,胎粪是一种非侵入性的
一种同时测试多种慢性暴露的方法
有毒物质,但目前还不清楚是否传统的生物标志物或
胎粪更能预测与特定的
有毒物质对于铅暴露,新出现的数据表明,我们的努力应该
强调一级预防,但铅危害的安全性和有效性
控制是不确定的,特别是对于低血铅儿童
浓度的研究人员建议进行一个纵向队列研究,
对400名儿童的研究,从妊娠不到16周到36个月
研究低水平照射(照射前和照射后)的剂量反应,
出生后)与神经行为结果的流行神经毒物,
发育障碍,如行为障碍、认知缺陷、听力障碍
注意力缺陷多动障碍的行为调查人员还将进行
一项巢式随机对照试验,以测试铅危害的有效性
控制或不良神经行为影响的发展。项目1
加州大学中心格兰特研究中心的研究人员将测试
以下假设:1)通过调查测量的子宫内暴露(酒精和
ETS)、母体和脐带血(铅、汞、杀虫剂和ETS)和尿液
(农药)对普遍毒物在子宫内的影响预测性较低,
如认知、行为问题、生长和听力,
胎粪中含有相同的有毒物质。2)产后接触杀虫剂、ETS和
铅(血液中铅含量低于10微克/分升)与
神经行为影响、生长延迟和儿童早期听力损失。第三章
减少铅摄入组的儿童血铅水平为2.7
ug/dl(30%)或更低,认知评分显著升高,听力降低
损失,更大的增长速度,和更少的行为问题比控制
36个月龄组。
如果得到资助,该项目与项目2的具体目标相结合,
验证胎粪作为子宫内暴露的标志物,将作为模型,
评估暴露于多种常见毒物的不良影响,
验证胎粪作为子宫内暴露于许多有毒物质的量度,
提供住宅杀虫剂的接触和风险评估数据,测试和
亚临床铅中毒的一级预防干预,
铅危害控制对儿童的有效性?血铅浓度
和神经行为功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRUCE P LANPHEAR其他文献
BRUCE P LANPHEAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRUCE P LANPHEAR', 18)}}的其他基金
Fluoride in Tooth Dentin and Neurodevelopmental Outcome in a Canadian Cohort
加拿大队列中牙齿牙本质中的氟化物和神经发育结果
- 批准号:
10176168 - 财政年份:2019
- 资助金额:
$ 17.91万 - 项目类别:
Fluoride in Tooth Dentin and Neurodevelopmental Outcome in a Canadian Cohort
加拿大队列中牙齿牙本质中的氟化物和神经发育结果
- 批准号:
10017974 - 财政年份:2019
- 资助金额:
$ 17.91万 - 项目类别:
Fluoride in Tooth Dentin and Neurodevelopmental Outcome in a Canadian Cohort
加拿大队列中牙齿牙本质中的氟化物和神经发育结果
- 批准号:
10434821 - 财政年份:2019
- 资助金额:
$ 17.91万 - 项目类别:
Fluoride in Tooth Dentin and Neurodevelopmental Outcome in a Canadian Cohort
加拿大队列中牙齿牙本质中的氟化物和神经发育结果
- 批准号:
10813234 - 财政年份:2019
- 资助金额:
$ 17.91万 - 项目类别:
A Community-Based Trial to Prevent Lead Poisoning and Injuries
预防铅中毒和伤害的社区试验
- 批准号:
7813987 - 财政年份:2007
- 资助金额:
$ 17.91万 - 项目类别:
A Community-Based Trial to Prevent Lead Poisoning and Injuries
预防铅中毒和伤害的社区试验
- 批准号:
7234588 - 财政年份:2007
- 资助金额:
$ 17.91万 - 项目类别:
A Community-Based Trial to Prevent Lead Poisoning and Injuries
预防铅中毒和伤害的社区试验
- 批准号:
7658278 - 财政年份:2007
- 资助金额:
$ 17.91万 - 项目类别:
A Community-Based Trial to Prevent Lead Poisoning and Injuries
预防铅中毒和伤害的社区试验
- 批准号:
7469574 - 财政年份:2007
- 资助金额:
$ 17.91万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 17.91万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 17.91万 - 项目类别:














{{item.name}}会员




